Ketamine, Dissociation, and Depression: What Is “Special” About Ketamine? (Revisited)
Mina M Rizk, James W. Murrough
The International Journal of Neuropsychopharmacology June 1, 2024 DOI: 10.1093/ijnp/pyae024 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Depression Esketamine Ketamine |
Abstract
In this issue of the Journal
Citations in the library
Cites 22
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Archives of General Psychiatry August 1, 2006
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial American Journal of Psychiatry August 28, 2013
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study American Journal of Psychiatry May 21, 2019
- Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS) Journal of Traumatic Stress 1998
and 17 more in the library